受精卵着床前丢失比例的估算研究
该研究结合流行病学、人口学、实验室及体外受精(IVF)数据构建经验框架,估算人类受精卵着床前丢失比例。在合理假设范围内,估计40%至50%的受精卵未能着床,且丢失风险在受精后最初数日最高。
要点
- 估计40%至50%的受精卵在着床前丢失
- 丢失风险在受精后最初数日最高
- 体外丢失可能多于体内,提示IVF成功率仍有提升空间
核心结论
- 在合理假设范围内,估计40%至50%的受精卵未能着床。
- 研究结果支持「受精后最初数日丢失风险最高」这一通常假设。
- 若估算准确,体外丢失的受精卵似乎多于体内,提示IVF成功率可能还有提升空间。
研究设计与样本
- 研究结合流行病学、人口学、实验室及IVF研究数据,构建估算着床前丢失的经验框架。
- 该框架汇总于补充材料中一个便于使用的Excel文件。
- 估算值可视为处于最佳生育年龄夫妇的平均水平。
主要发现
- 在不同合理假设下,估计40%至50%的受精卵未能着床。
- 已发表的着床前丢失估计范围为10%至70%。
- 着床前丢失无法用现有技术检测。
关键数值与推荐
- 体内受精率假设范围:64%(人类IVF数据)至90%(小鼠数据)。
- 估计40%至50%的受精卵未能着床。
临床怎么用
- 为咨询夫妇提供着床前丢失的量化参考,说明早期丢失较为常见。
- 强调丢失风险在受精后最初数日最高,有助于解释早期妊娠失败。
局限性
- 关键参数受精概率仅有IVF人类数据,可能不能准确代表体内过程。
- 因此采用64%至90%的体内受精率假设范围,估算存在不确定性。
- 着床前丢失无法直接检测,估算依赖多重假设。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: What proportion of fertilized human ova are lost before implantation? SUMMARY ANSWER: An estimated 40 to 50% of fertilized ova fail to implant. WHAT IS KNOWN ALREADY: Preimplantation loss is not detectable with current technology. Published estimates of preimplantation loss range from 10 to 70%. STUDY DESIGN, SIZE, DURATION: We combine data from epidemiologic, demographic, laboratory and in vitro fertilization studies to construct an empirical framework for the estimation of preimplantation loss. This framework is summarized in a user-friendly Excel file included in supplement. PARTICIPANTS/MATERIALS, SETTING, METHODS: We draw from multiple sources to generate plausible estimates of fecundability, sterility, transient anovulation, intercourse patterns and the proportion of ova fertilized in the presence of sperm. We combine these estimates to generate a summary estimate of preimplantation loss. This estimate can be considered an average for couples in their prime reproductive years. MAIN RESULTS AND THE ROLE OF CHANCE: Under a plausible range of assumptions, we estimate that 40 to 50% of fertilized ova fail to implant. LIMITATIONS, REASONS FOR CAUTION: A crucial factor in estimating preimplantation loss is the probability that an ovum will be fertilized when exposed to sperm. Human data are available only from in vitro fertilization (IVF), which may not accurately represent events in vivo. We therefore assume a range of in vivo fertilization rates, from 64% (human IVF data) to 90% (mouse data). WIDER IMPLICATIONS OF THE FINDINGS: Our estimate of preimplantation loss takes into account the biological processes relevant to fertilization and loss. Using this empirical basis for estimation, we find support for the usual assumption that risk of loss is highest in the earliest days following fertilization. Furthermore, this framework can provide improved estimates as better reproductive data become available. To the extent that our estimates are accurate, more fertilized ova are apparently lost in vitro than in vivo, suggesting that further improvements in IVF success rates may be possible. STUDY FUNDING/COMPETING INTEREST(S): This study was supported by the Intramural Program of the National Institute of Environmental Health Sciences, NIH. Professor Adashi serves as Co-Chair of the Safety Advisory Board of Ohana Biosciences, Inc. The other authors have no competing interests. TRIAL REGISTRATION NUMBER: N/A.
引用
- Wilcox AJ, Harmon Q, Doody K, et al. Preimplantation loss of fertilized human ova: estimating the unobservable. Hum Reprod. 2020. PMID: 32296829. doi:10.1093/humrep/deaa048
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。